Reducing stomach acid levels is often insufficient in treating symptoms of gastroesophageal reflux disease in neonates, according to a news release by the Nationwide Children's Hospital.
Researchers at Nationwide Children's Hospital report that GERD is a frequent consideration in infants at risk of the life-threatening events chronic lung disease and dysphagia, but the definition of GERD in neonates and its treatment remain controversial. Acid suppressive medications and prokinetics can have harmful side effects.
The study found that 54 percent of reflux events documented by pH-impedance were associated with symptoms and more than 87 percent of the pH-only events were associated with symptoms.
Read the Nationwide Children's Hospital release on treating neonates with GERD symptoms.
Related Articles on GERD:
Patients With Severe GERD More Likely to be Screened for Cancer
Study: Infants' GERD Symptoms Do Not Improve From Proton-Pump Inhibitors
Surgeons Use Transoral Incisionless Fundoplication to Treat GERD